Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Fingolimod therapy in multiple sclerosis--the issue of the pathomechanism].
Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
A novel approach with "skeletonised MTR" measures tract-specific microstructural changes in early primary-progressive MS.
Assessment of upper extremity function in multiple sclerosis: review and opinion.
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
T Cell Mediated Pathogenesis in EAE: Molecular Mechanisms.
Morphometric and quantitative immunohistochemical analysis of disease-related changes in the upper (suburothelial) lamina propria of the human bladder dome.
The Norwegian Multiple Sclerosis Registry and Biobank.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Yes.
Embryonic stem cells in multiple sclerosis.
Glial cells suppress postencephalitic CD8(+) T lymphocytes through PD-L1.
The central role of mitochondria in axonal degeneration in multiple sclerosis.
Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.
Multiple sclerosis: Cognitive training provides lasting benefits for patients with multiple sclerosis.
Treatment strategies for multiple sclerosis: When to start, when to change, when to stop?
Ischemic Preconditioning in White Matter: Magnitude and Mechanism.
[Current aspects of therapy conversion for multiple sclerosis].
An 8-Year-Old Boy With Ascending Paralysis.
CSF cytokines/chemokines as biomarkers in neuroinflammatory CNS disorders: A systematic review.
POLG mutations associated with remitting/relapsing neurological events.
Persistent Inflammation in the CNS during Chronic EAE Despite Local Absence of IL-17 Production.
Targeting ion channels for the treatment of autoimmune neuroinflammation.
Molecular biomarkers of neurodegeneration.
Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
Vitamin D receptor Bsm1 polymorphism, calcium metabolism and bone mineral density in patients with multiple sclerosis: a pilot study.
Pages
« first
‹ previous
…
409
410
411
412
413
414
415
416
417
…
next ›
last »